| MPM BioVentures 2014, L.P. |
3.3% |
1,394,624 |
1,394,624 |
0 |
/s/ Ansbert Gadicke |
Managing Director of MPM BioVentures 2014 LLC, the Managing Member of MPM BioVentures 2014 GP LLC, the General Partner of MPM BioVentures 2014, L.P. |
0001609492 |
| MPM BioVentures 2014 (B), L.P. |
0.2% |
93,019 |
93,019 |
0 |
/s/ Ansbert Gadicke |
Managing Director of MPM BioVentures 2014 LLC, Managing Member of MPM BioVentures 2014 GP LLC, the General Partner of MPM BioVentures 2014 (B), L.P |
0001609493 |
| MPM Asset Management Investors BV2014 LLC |
0.1% |
48,001 |
48,001 |
0 |
/s/ Ansbert Gadicke |
Managing Director of MPM BioVentures 2014 LLC, the manager of MPM Asset Management Investors BV2014 LLC |
0001609495 |
| UBS Oncology Impact Fund L.P. |
2.6% |
1,122,888 |
1,122,888 |
0 |
/s/ Ansbert Gadicke |
Managing Partner of MPM BioImpact LLC, the GP of Oncology Impact Fund (Cayman) Management L.P., the GP of UBS Oncology Impact Fund L.P. |
0001691428 |
| MPM BioVentures 2014 GP LLC |
3.5% |
1,487,643 |
0 |
1,487,643 |
/s/ Ansbert Gadicke |
Managing Director of MPM BioVentures 2014 LLC, the Managing Member of MPM BioVentures 2014 GP LLC |
0001765091 |
| MPM BioVentures 2014 LLC |
3.6% |
1,535,644 |
0 |
1,535,644 |
/s/ Ansbert Gadicke |
Managing Director |
0001765021 |
| Oncology Impact Fund (Cayman) Management L.P. |
2.6% |
1,122,888 |
0 |
1,122,888 |
/s/ Ansbert Gadicke |
Managing Partner of MPM BioImpact LLC, the General Partner of Oncology Impact Fund (Cayman) Management L.P. |
0001721036 |
| MPM BioImpact LLC |
2.6% |
1,122,888 |
0 |
1,122,888 |
/s/ Ansbert Gadicke |
Managing Partner |
0001687078 |
| ANSBERT GADICKE |
6.3% |
2,658,532 |
0 |
2,658,532 |
/s/ Ansbert Gadicke |
Ansbert Gadicke |
0001134655 |
| LUKE EVNIN |
3.6% |
1,535,644 |
0 |
1,535,644 |
/s/ Luke Evnin |
Luke Evnin |
0001134657 |
| Todd Foley |
3.6% |
1,535,644 |
0 |
1,535,644 |
/s/ Todd Foley |
Todd Foley |
0001473930 |